Role of the proteasome in Alzheimer's disease

被引:87
作者
Checler, F [1 ]
da Costa, CA [1 ]
Ancolio, K [1 ]
Chevallier, N [1 ]
Lopez-Perez, E [1 ]
Marambaud, P [1 ]
机构
[1] CNRS, Inst Pharmacol Mol & Cellulaire, UPR411, F-06560 Valbonne, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2000年 / 1502卷 / 01期
关键词
proteasome; presenilin; degradation; beta-amyloid; APP alpha;
D O I
10.1016/S0925-4439(00)00039-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The proteasome is a multicatalytic complex involved in the degradation of polyubiquitinated proteins. Here we review the clues of a possible involvement of the proteasome in Alzheimer's disease neuropathology. Thus, we discuss the fact that the proteasome modulates the intracellular concentrations of presenilins 1 and 2. These two proteins, when mutated, appear responsible for most of early onset forms of Alzheimer's disease and this is thought to be due to the exacerbation of the pathogenic pathway of the maturation of the beta-amyloid precursor protein. Controlling presenilins concentrations could have drastic repercussions on cell physiology as suggested by the fact that proteasome inhibitors drastically potentiate the 'normal' or 'pathogenic' presenilins phenotype related with beta APP processing. The possibility of considering the proteasome as a potential tar-get for therapeutic intervention ill Alzheimer's disease is discussed. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 39 条
[1]
alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease [J].
Ancolio, K ;
Marambaud, P ;
Dauch, P ;
Checler, F .
JOURNAL OF NEUROCHEMISTRY, 1997, 69 (06) :2494-2499
[2]
Characterization of new polyclonal antibodies specific for 40 and 42 amino acid long amyloid beta peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases [J].
Barelli, HL ;
Lebeau, A ;
Vizzavona, J ;
Delaere, P ;
Chevallier, N ;
Drouot, C ;
Marambaud, P ;
Ancolio, K ;
Buxbaum, JD ;
Khorkova, O ;
Heroux, J ;
Sahasrabudhe, S ;
Martinez, J ;
Warter, JM ;
Mohr, M ;
Checler, F .
MOLECULAR MEDICINE, 1997, 3 (10) :695-707
[3]
Presenilins - Structural aspects and posttranslational events [J].
Checler, F .
MOLECULAR NEUROBIOLOGY, 1999, 19 (03) :255-265
[4]
Presenilins: Multifunctional proteins involved in Alzheimer's disease pathology [J].
Checler, F .
IUBMB LIFE, 1999, 48 (01) :33-39
[5]
CHECLER F, 1995, J NEUROCHEM, V65, P1431
[6]
Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor κB1 [J].
Coux, O ;
Goldberg, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8820-8828
[7]
Structure and functions of the 20S and 26S proteasomes [J].
Coux, O ;
Tanaka, K ;
Goldberg, AL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :801-847
[8]
C-terminal maturation fragments of presenilin 1 and 2 control secretion of APPα and Aβ by human cells and are degraded by proteasome [J].
da Costa, CA ;
Ancolio, K ;
Checler, F .
MOLECULAR MEDICINE, 1999, 5 (03) :160-168
[9]
ALTERED CLEAVAGE AND SECRETION OF A RECOMBINANT BETA-APP BEARING THE SWEDISH FAMILIAL ALZHEIMERS-DISEASE MUTATION [J].
FELSENSTEIN, KM ;
HUNIHAN, LW ;
ROBERTS, SB .
NATURE GENETICS, 1994, 6 (03) :251-256
[10]
Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome [J].
Fergusson, J ;
Landon, M ;
Lowe, J ;
Dawson, SP ;
Layfield, R ;
Hanger, DP ;
Mayer, RJ .
NEUROSCIENCE LETTERS, 1996, 219 (03) :167-170